HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Chiefari, Eusebio ^a   Nevolo, Maria T ^a   Arcidiacono, Biagio ^a   Maurizio, Elisa ^b   Nocera, Aurora ^a   Iiritano, Stefania ^a   Sgarra, Riccardo ^b   Possidente, Katiuscia ^a   Palmieri, Camillo ^a   Paonessa, Francesco ^a   Brunetti, Giuseppe ^c   Manfioletti, Guidalberto ^b   Foti, Daniela ^a   Brunetti, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859735682     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00251     Document Type: Article

References (39)

1. Bustin, M. & Reeves, R. High-mobility group proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acids Res. 54, 35-100 (1996).
2. Reeves, R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277, 63-81 (2001). (Pubitemid 32972109)
3. Thanos, D. & Maniatis, T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100 (1995). (Pubitemid 26007801)
4. Oñate, S. A. et al. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol. Cell. Biol. 14, 3376-3391 (1994).
5. Falvo, J. V., Thanos, D. & Maniatis, T. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y).Cell 83, 1101-1111 (1995). (Pubitemid 26007802)
6. Reeves, R. & Nissen, M. S. Cell cycle regulation and functions of HMG-I(Y) Prog. Cell Cycle Res. 1, 339-349 (1995).
7. Huth, J. R. et al. The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat. Struct. Biol. 4, 657-665 (1997). (Pubitemid 27323449)
8. Edberg, D. D., Bruce, J. E., Siems, W. F. & Reeves, R. In vivo post-translational modifications of the High Mobility Group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry 43, 11500-11515 (2004). (Pubitemid 39186971)
9. Sgarra, R. et al. Macroscopic differences in HMGA oncoproteins posttranslational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties. J. Proteome Res. 8, 2978-2989 (2009).
10. Wang, D-Z., Ray, P. & Boothby, M. Interleukin 4-inducible Phosphorylation of HMG-I(Y) is Inhibited by Rapamycin. J. Biol. Chem. 270, 22924-22932 (1995).
11. Brunetti, A., Manfioletti, G., Chiefari, E., Goldfine, I. D. & Foti, D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y).FASEB J. 15, 492-500 (2001). (Pubitemid 32141441)
12. Foti, D., Iuliano, R., Chiefari, E. & Brunetti, A. A nucleoprotein complex containing Sp1, C/EBPb, and HMGI-Y controls human insulin receptor gene transcription. Mol. Cell. Biol. 23, 2720-2732 (2003). (Pubitemid 36403073)
13. Baxter, R. C. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am. J. Physiol. Endocrinol. Metab. 278, E967-E976 (2000). (Pubitemid 30439132)
14. Clemmons, D. R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev. 8, 45-62 (1997). (Pubitemid 27214688)
15. Lee, P. D. K., Conover, C. A. & Powell, D. R. Regulation and function of insulinlike growth factor-binding protein-1. Proc. Soc. Exp. Biol. Med. 204, 4-29 (1993). (Pubitemid 23274051)
16. Allander, S. V. et al. Hepatic nuclear factor 3 and high mobility group I/Y proteins bind the insulin response element of the insulin-like growth factor-binding protein-1 promoter. Endocrinology 138, 4291-4300 (1997). (Pubitemid 27408473)
17. Foti, D. et al. Lack of the architectural factorHMGA1causes insulin resistance and diabetes in humans and mice. Nat. Med. 11, 765-773 (2005). (Pubitemid 41021209)
18. Arcaro, A. & Wymann, M. P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3, 4, 5-trisphosphate in neutrophil responses. Biochem. J. 296, 297-301 (1993). (Pubitemid 23350826)
19. Drobic, B., Pérez-Cadahìa, B., Yu, J., Kung, S. K. & Davie, J. R. Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex. Nucleic Acids Res 38, 3196-3208 (2010).
20. Piekielko, A. et al. Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem 276, 1984-1992 (2001). (Pubitemid 32109677)
21. Sgarra, R. et al. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett 574, 1-8 (2004). (Pubitemid 39200885)
22. Pender, C. et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: relationship to hyperinsulinemia. Int. J. Obes. Relat. Metab. Disord. 28, 363-369 (2004). (Pubitemid 38296948)
23. Brunetti, A., Maddux, B. A., Wong, K. Y. & Goldfine, I. D. Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels. J. Clin. Invest. 83, 192-198 (1989). (Pubitemid 19048423)
24. Brunetti, A., Foti, D. & Goldfine, I. D. Identification of unique nuclear regulatory proteins for the insulin receptor gene, which appear during myocyte and adipocyte differentiation. J. Clin. Invest. 92, 1288-1295 (1993). (Pubitemid 23273904)
25. Goldfine, I. D. The insulin receptor: molecular biology and transmembrane signalling. Endocr. Rev. 8, 235-255 (1987).
26. Kahn, C. R. The molecular mechanisms of insulin action. Annu. Rev. Med. 36, 429-451 (1985).
27. Czech, M. P. The nature and regulation of insulin receptor: structure and function. Annu. Rev. Physiol. 47, 357-381 (1985). (Pubitemid 15142387)
28. Lewitt, M. S., Denyer, G. S., Cooney, G. J. & Baxter, R. C. Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 129, 2254-2256 (1991).
29. Rajkumar, K., Krsek, M., Dheen, S. T. & Murphy, L. J. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J. Clin. Invest. 98, 1818-1825 (1996). (Pubitemid 26359199)
30. Chiefari, E. et al. The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol. 7, 24 (2009).
31. Dey, D. et al. Inhibition of insulin receptor gene expression and insulin signaling by fatty acid: interplay of PKC isoforms therein. Cell. Physiol. Biochem. 16, 217-228 (2005). (Pubitemid 41643021)
32. Chiefari, E. et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 305, 903-912 (2011).
33. Chiefari, E. et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat. Commun. 1, 40 (2010).doi:10. 1038/ncomms1040.
34. Desvergne, B., Michalik, L. & Wahli, W. Transcriptional regulation of metabolism. Physiol. Rev. 86, 465-514 (2006).
35. Czech, M. P. Insulin's expanding control of forkheads. Proc. Natl. Acad. Sci. USA 100, 11198-11200 (2003). (Pubitemid 37205911)
36. Puig, O. & Tjian, R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435-2446 (2005). (Pubitemid 41483691)
37. Paonessa, F. et al. Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. Cancer Res. 66, 5085-5093 (2006). (Pubitemid 43844930)
38. Vitvitsky, V. et al. Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R39-R46 (2004). (Pubitemid 38856309)
39. Gerrish, K., Cissell, M. A. & Stein, R. The role of hepatic nuclear factor 1a and PDX-1 in transcriptional regulation of the pdx-1 gene. J. Biol. Chem. 276, 47775-47784 (2001).